1 a protein with homology to G-proteincoupled receptors, was first identified in Drosophila as a necessary component for Hedgehog signaling and shown to be involved in pattern formation and morphogenesis (1-4). Subsequent studies revealed that Smo is the signaling component of the vertebrate Sonic hedgehog (Shh) receptor complex (5) and, along with Patched (Ptc), contributes to the causation of basal cell carcinoma (6 -10). Smo is known to be constitutively active in the absence of Ptc, and its third intracellular loop and seventh transmembrane region are required for function (11). However, Smo has yet to be shown to interact with a G-protein, and the identity of the pathway used for downstream communication is unclear (12, 13).
Smoothened (Smo), 1 a protein with homology to G-proteincoupled receptors, was first identified in Drosophila as a necessary component for Hedgehog signaling and shown to be involved in pattern formation and morphogenesis (1) (2) (3) (4) . Subsequent studies revealed that Smo is the signaling component of the vertebrate Sonic hedgehog (Shh) receptor complex (5) and, along with Patched (Ptc), contributes to the causation of basal cell carcinoma (6 -10) . Smo is known to be constitutively active in the absence of Ptc, and its third intracellular loop and seventh transmembrane region are required for function (11) . However, Smo has yet to be shown to interact with a G-protein, and the identity of the pathway used for downstream communication is unclear (12, 13) .
Because detection of a G-protein-coupled response from Smo in transfected mammalian cells has been elusive, we were prompted to examine its effect using a frog melanophore-based assay. Melanophores provide a sensitive, quantitative bioassay for the activity of G-protein-coupled receptors (14) . The state of pigment distribution within a cell reflects intracellular levels of cyclic adenosine monophosphate (cAMP) or diacylglycerol. Elevation of either cAMP or diacylglycerol above baseline induces melanosome dispersion throughout the cytoplasm, whereas inhibition of cAMP production (in the absence of additional diacylglycerol production) is associated with melanosome aggregation into a single, centrally located sphere. The melanophore assay is particularly useful as a means of identifying G␣ icoupled receptors, such as the human D 3 receptor, whose ability to lower intracellular cAMP levels is barely noticeable when heterologously expressed (15) .
Here, it is demonstrated that Xenopus melanophores expressing Smo display persistent aggregation, a hallmark of G␣ i activity. Either pertussis toxin (PTX) or a dominant negative G␣ i , but not a dominant negative G␣ o , can reverse the phenotype. The results show that Smoothened can signal via activation of G␣ i .
EXPERIMENTAL PROCEDURES
Plasmid DNA Constructs-The human cannabinoid receptor 2 (CB2) was the kind gift of Merck Frosst. Plasmid pRK7 containing the human Smo, Ptc, and mouse Shh genes and purified, recombinant N-Shh (5) were obtained from Genentech, Inc. Clones for rat wild type G␣ i1 , G␣ oa , and the G␣ i1 S47N mutant (16) were a gift from Dr. Alfred Gilman and G␣ i1 Q204H was obtained from Dr. Stephen Sprang, both at the University of Texas Southwestern Medical Center. The coding sequences were subcloned into either pCR3.1 Uni (Smo) or pcDNA3.1/V5/His-TOPO (G␣ i and G␣ o ) vectors from Invitrogen for expression in melanophores. G␣ o Q205L and S47C were constructed using the Transformer Mutagenesis kit from Promega.
Transfections-The ␤ 2 -7 cell line of Xenopus melanophores, obtained from Bunsen Rush Laboratories, Inc., was propagated as described in fibroblast-conditioned medium (CFM) (14) . Cells were transfected by electroporation using an Electro Cell Manipulator 600 (BTX) as described with the following changes (16) . A constant amount of DNA (40 g) consisting of plasmid and sheared salmon sperm DNA carrier (Life Technologies, Inc.) dissolved in 10 l of 10 mM Tris-EDTA, pH 7.5, was added to 1 ϫ 10 6 cells suspended in 400 l of 70% phosphatebuffered saline, pH 7.0. The resulting mix was incubated on ice for 20 min in a 1.5-ml Eppendorf tube and twice vortexed gently during this period. The cells were triturated with a micropipettor, transferred to a prechilled 2-mm gap cuvette, and electroporated at settings of 450 microfarads, 475 V, and 720 ohms. Cells were resuspended in 6 ml of CFM containing 100 nM melanocyte stimulating hormone and 5 mg/ml insulin, plated in T 25 flasks and allowed to attach for 3 h. Flasks were rinsed with 70% phosphate-buffered saline, pH 7.3, to remove dead cells, trypsinized with 0.3 ml of 0.5ϫ trypsin-EDTA, and resuspended in 10 ml of CFM containing melanocyte stimulating hormone and insulin. Cells were plated in 96-well half-area plates at 100% confluence for microplate assays and at 10% confluence in 6-well plates (Costar) pretreated with Cell-Tak (Collaborative Research) for manual counting.
Microplate Assays-Microplate assays measuring the mean G␣ i -dependent aggregation of melanophore pigment were performed as described (17) with the following changes. 24 h following plating, medium was removed and replaced with 100 l of serum-free 70% L-15 medium (L-15, Sigma). Cells were incubated in white light for 1 h, and 11 l of L-15 containing ten times the final concentration of ligands was added and designated as time zero. Absorbance at 650 nM was immediately measured on a Molecular Dynamics V max microplate reader using the SOFTmax program. Cells were exposed to white light for 30 min, and final absorbances were measured.
Cell Counting-To determine the ratio of cells with aggregated versus dispersed pigment, fields of cells in 6-well plates were examined using a Nikon Eclipse TE300 microscope at 20ϫ magnification under bright field optics. 24 h following plating, complete medium was removed and replaced with L-15, and cells were incubated in white light for 1 h. 3-10 fields, containing a total of 250 -300 cells, were randomly chosen and photographed to calculate the percentage of cells with aggregated pigment for each data point. Cells were either scored as aggregated (round) or dispersed (stellate). Experiments were repeated at least three times, and error bars show standard errors of the means.
PTX Assay-PTX from List Biological Labs Inc. was reconstituted according to the supplier's instructions. ␤ 2 -7 melanophores were electroporated with 10 g of Smo and 30 g of salmon sperm DNA, 10 g of CB2 receptor plasmid and 30 g of salmon sperm DNA, or 40 g of salmon sperm DNA alone (control). Transfected cells were plated as described above in Cell-Tak-coated 96-well plates (Corning). After an overnight incubation at 30°C in the dark, cells were exposed to white light for 1 h in the incubator. Absorbance was measured at time zero, and compounds were added to wells to give a final concentration of 5 g/ml PTX, 100 nM HU210 (CB2 receptor agonist), and 10 nM melatonin. Plates were returned to the illuminated incubator, and additional readings were taken every hour.
␤-Galactosidase Assay-Transfection efficiency was assayed by cotransfection with 4 g of a lacZ-encoding plasmid (15, 18) . 24 h following plating, medium was removed and replaced with L-15. Cells were exposed to white light for 1 h, fixed, and incubated in ␤-galactosidase assay buffer for 24 h. 40 -70% of cells consistently exhibited blue color.
RESULTS

Smo Expression in Melanophores Causes Pigment Aggregation-Because
Smo is constitutively active in the absence of the inhibitory co-receptor Ptc, its expression in melanophores would be expected to lead to a phenotype of persistent pigment dispersion if it coupled to either G␣ s or G␣ q . Alternatively, pigment aggregation would be expected to occur if Smo coupled to G␣ i . 10 g of the plasmid pCR3.1 Uni containing wild type human Smo cDNA (Smo) (Fig. 1, A and B) , or pCR3.1 Uni vector control (Fig. 1 , C and D) were transfected into Xenopus melanophores and placed in the dark. 24 h post-transfection, the medium was replaced with L-15 and the plates were returned to the dark for 1 h. The melanophores were then immediately photographed (Fig. 1 , A and C), exposed to white light for 1 h, and rephotographed ( Fig. 1, B and D) . Unlike some other melanophore cell lines, the ␤2-7 cells used in these experiments remain mostly dispersed in the dark, and light causes only a 12% increase in overall darkening (data not shown) (19, 20) . Whereas a few cells in the plate that received Smo did disperse their pigment in response to light (not shown), Ͼ90% showed the phenotype of pigment aggregation both before (Fig. 1A) and after ( Fig. 1B) exposure to light. Meanwhile, all of the cells in the plate that received only control vector maintained the pigment dispersed state both before ( Fig. 1C ) and after photostimulation (Fig. 1D) .
PTX Reverses Smo-induced Pigment Aggregation-Because the only pathway known to induce pigment aggregation in melanophores is via G␣ i signaling, PTX, an inhibitor of both G␣ i and G␣ o (21) , was applied following transfection with Smo ( Fig. 2) . Twenty-four hours after electroporation, the plate was treated with 5 g/ml PTX and exposed to white light ( Fig. 2A) . Absorbance measurements were obtained at hourly intervals in the continued presence of photostimulation. For the first 4 h, no changes in pigment distribution were observed in either the PTX-treated cells or the controls that did not receive PTX. After that time, and for the rest of the 9-h experiment, the PTXtreated cells displayed increasing pigment dispersion, as determined by a sustained increase in absorption, whereas the control cells remained unchanged.
As additional tests, melanophores were transfected with either salmon sperm DNA or a vector coding for the human CB2 that is known to function via activation of G␣ i (22) (Fig. 2, B and C). To wells containing salmon sperm DNA-transfected cells (Fig. 2B ) 5 g/ml PTX was added with or without 10 nM melatonin, which activates the endogenous G␣ i -linked melatonin receptor. In the first hour, melatonin-treated cells aggregated their pigment, as determined by a decrease in absorbance, whether or not PTX was present. Over the subsequent 8 h, the PTX-treated cells showed continued pigment dispersion, whereas the ones that received only melatonin kept their melanosomes tightly aggregated. The reason for the more rapid response to PTX by sham-transfected cells that received melatonin compared with Smo-transfected cells is not known. However, because of the robustness of the cytomegalovirus promoter used to drive Smo expression, one possibility is that the number of Smo molecules expressed on the cell surface is greater then that of the native melatonin receptor. This could increase the amount of time required for the PTX to inhibit a comparable number of G-proteins in the Smo experiment, compared with the melatonin one, to negate the receptor-mediated pigment aggregation signal. As additional controls, melatonin was withheld, and the effect of PTX alone was examined. Here, PTX was ineffective at inducing additional pigment dispersion above the starting base line, as was also the case for melanophores that saw neither PTX nor melatonin.
As a further test, cells transfected with the CB2 receptor were given 100 nM of the CB2 receptor agonist, HU210, with or without the simultaneous addition of PTX (Fig. 2C) . Cells that received HU210 alone showed a steady decrease in absorbance, indicative of pigment aggregation, throughout the 9-h experiment. Meanwhile, cells that received both HU210 and PTX showed a decrease in absorbance for the first 4 h. Thereafter, as with the case for Smo-expressing cells, increasing pigment dispersion was observed. As additional controls, the effect of PTX on CB2 receptor-transfected cells that were not given HU210 was tested. Melanophores that received neither HU210 nor PTX had no observable change in their pigment distribution throughout the experiment. However, those that received PTX responded with an increase in absorbance above the baseline beginning at 4 h. This latter effect is most easily explained by the possibility that, in melanophores, the CB2 receptor shows a small amount of constitutive activity.
Constitutively and/or G␣ o could contribute to Smo-mediated pigment aggregation, two experiments were conducted. Because receptormediated G␣ i activation is known to cause pigment aggregation, it was expected that expression of a constitutively active G␣ i would have such an effect. This was confirmed by electroporation with several concentrations of a mutant G␣ i vector that is always active, G␣ i Q204H. 24 h following the electroporation and plating in 6-well plates, the medium was changed to L-15, and the cells were exposed to light for 1 h. The numbers of cells found to have aggregated versus dispersed pigment were determined by examining and tallying individual cells as described under "Experimental Procedures." As seen in Fig. 3A , there was a dose-dependent relationship between the amount of vector applied and the percentage of resulting cells that had aggregated pigment. With regard to G␣ o , although melanophores contain an endogenous protein (data not shown), its contribution to pigment distribution following receptor-mediated stimulation has been obscure. To evaluate the potential for G␣ o stimulation to mediate pigment movement, constitutively active G␣ o Q205L was introduced into the pigment cells. As with active G␣ i , G␣ o also produced dose-dependent persistent pigment aggregation (Fig. 3A) .
Because PTX reversed Smo-mediated melanosome aggregation while either constitutively active G␣ i or G␣ o were found to be independently capable of inducing aggregation, the specific contributions of G␣ i and G␣ o to the Smo effect were tested. A dominant negative G␣ i (23) and a dominant negative G␣ o were coexpressed with Smo in melanophores. In the absence of Smo, over 90% of the melanophores had dispersed pigment, regardless of whether dominant negative G␣ i or G␣ o was present (Fig. 3B) . However, 30 g of the dominant negative G␣ i S47N largely blocked the ability of 10 g of Smo to induce pigment aggregation, whereas an identical quantity of vector coding for the dominant negative G␣ o S47C had no effect.
Since only the dominant negative G␣ i could prevent Smoinduced pigment aggregation, the G␣ i effect was examined in more detail (Fig. 3, C and D) . Increasing the amount of Smo from 1 to 16 g led to increased pigment aggregation up to a maximum value of 47% (Fig. 3C) . Because the electroporation efficiency in these experiments was on the order of 70% by ␤-galactosidase staining (not shown), the 47% value means that 67% of electroporated cells experienced pigment aggregation. Cells cotransfected with Smo and G␣ i S47N also showed an increase in the numbers of cells with pigment aggregation but the effect was more modest, with a maximum of 17% of the total or 24% of the electroporated ones. Expression of G␣ i S47N was therefore able to block Smo-mediated aggregation by about 64%. Similarly, 30 g of G␣ i S47N cotransfected with 4 g of CB2 receptor was able to block HU210-induced aggregation by 58% (data not shown). Next, cotransfection was carried out where the amount of dominant negative G␣ i used during transfection varied in the presence of a constant 10 g of Smo (Fig. 3D) . Here, the dominant negative G␣ i reversed Smo-induced aggregation, again in a dose-dependent manner. 10 g of 6-His G␣ i1 S47N, an ␣-subunit that is nonfunctional in vivo because of lack of myris- toylation (16) , was also tested for its ability to inhibit Smoinduced aggregation and was found to be ineffective (Fig. 3D) .
Ptc Blocks Smo Activity in Melanophores and Shh Reverses the Block-In its native environment, Smo is held in check by
the co-receptor, Ptc. To determine if this aspect of Smo regulation is correctly preserved during expression in melanophores, a Ptc⅐Smo co-expression experiment was conducted (Fig. 4A) . 10 g of the Smo vector was electroporated into melanophores along with 0 -10 g of vector containing an insert coding for human Ptc. As expected, in the absence of Ptc ϳ55% of the cells showed pigment aggregation, reflecting the efficiency of transfection by electroporation. However, the addition of 0.5 g of the Ptc vector to the transfection resulted in a greater than 50% reduction in the number of pigment-aggregated cells, to ϳ25% of the total. vector control transfection nor one carried out with Ptc alone led to cells displaying pigment aggregation (Fig. 4A) . Melatonin, which operates on the endogenous melatonin receptor, was not inhibited from effecting G␣ i -mediated melanosome aggregation by Ptc (data not shown). Therefore, Ptc expression per se did not prevent G␣ i -mediated pigment aggregation.
To confirm that the Ptc⅐Smo receptor complex as a whole also maintained its normal signaling capability when expressed by melanophores, a triple co-expression experiment was conducted using plasmids coding for Shh, Ptc, and Smo (Fig. 4B) . 10 g each of Ptc and Smo-expressing plasmids were electroporated into cells along with 0 -10 g of a plasmid whose expression induces Shh secretion from the cells. As previously shown in Fig. 4A , in the absence of Shh, the percentage of cells found in the pigment-aggregated state was again minimal. However, the addition of 1 g of the Shh plasmid to the electroporation led to a greater than 50% reestablishment of the number of cells found to have aggregated pigment, compared with cells expressing only Smo. Further addition of Shh vector resulted in full restoration of the percentage of pigment-aggregated cells compared with either the expression of Smo alone or Smo plus Shh but absent of Ptc. As expected, Shh expression alone did not induce pigment aggregation. The cells electroporated with only the Shh vector also retained their ability to aggregate pigment in response to melatonin (data not shown).
Shh Mediates Rapid Pigment Aggregation in Melanophores That Co-express Ptc and Smo-
The above experiments demonstrate that the Ptc⅐Smo receptor complex can be established and is functional in melanophores. They also demonstrate that Smo activation leads to G␣ i -mediated signaling. However, the phenotype of pigment aggregation occurred following continuous Smo activity, and Smo is known to induce the transcription of various proteins such as Gli1. Therefore it was possible that the observed G␣ i activation was an indirect effect, resulting from the induction of transcription and translation of a secondary protein(s) that in turn activated G␣ i . To rule out this possibility, Shh protein produced in Escherichia coli was applied to melanophores that co-expressed Ptc and Smo. 15 g of Ptc and 30 g of Smo were introduced into cells by electroporation, and the cells were plated at a density of 5000 cells/well in 96-well microtiter plates. Following an overnight incubation in CFM, cells were exposed to light for 1 h. Then, in the continuous presence of light, Shh was added to the wells to achieve a concentration of 3 g/ml, and the time course of the pigment aggregation response was determined over the subsequent 30 min (Fig. 5A) . Within 5 min, pigment aggregation was seen as measured by a decrease in absorbance compared with cells that did not see Shh. The difference between the Shh and non-Shh-treated cells became increasingly evident throughout the test. By comparison, melatonin induced noticeable pigment aggregation within 1 min. As an additional set of controls, cells electroporated with pCR3.1 Uni were also evaluated for their ability to aggregate pigment in response to Shh and melatonin (Fig. 5B) . Here, whereas melatonin again induced pigment aggregation, Shh had no effect. DISCUSSION The results show that Smo has the hallmarks of a G-proteincoupled receptor, consistent with its known sequence homology to other 7-transmembrane receptors. The constitutive activity in melanophores is also consistent with the current model for Smo function, wherein activity is seen in the absence of the inhibitory co-receptor, Ptc. The simplest interpretation of the results is that Smo interacts directly with G␣ i . However, to rule out the possibility of an unknown intermediary protein common to melanophores, keratinocytes, and other cells in which Smo functions, additional experiments would be necessary to show that Smo directly activates G-protein nucleotide exchange in membrane preparations. Coupling to G␣ i in pigment cells probably is recapitulated in vivo within basal keratinocytes and other cell types for four reasons. First, over 100 different G-protein-coupled receptors have been expressed in melanophores in our laboratory and by others without any failures. In all cases, the mechanism of coupling has faithfully reproduced those observed in their natural environments (15, 17) . Second, injection of mRNA encoding PTX into zebrafish embryos affects their development consistent with a role for G␣ i in the Hedgehog signaling pathway (24) . Third, another Frizzled family member, rat Frizzled-2, stimulates the phosphatidylinositol signaling pathway and protein kinase C via a PTX-sensitive G-protein (25, 26) . Fourth, although G␣ o activity was demonstrated to be capable of inducing pigment aggregation, a dominant negative G␣ o did not prevent Smo-mediated aggregation.
The findings lead to the suggestion that at least some of the 45% of basal cell carcinomas whose Ptc and Smo proteins are fully functional may harbor defects in G␣ i or downstream components of the G␣ i -regulated pathways. Inhibitors targeted to 15 were added to achieve a final concentration of 3 g/ml (squares) and 10 nM (triangles), respectively. L-15 was added to the control wells (circles). Time zero absorbance measurements were obtained directly after the addition of ligands. Over the following 30 min, absorbance measurements were taken at the indicated times. B, melanophores were transfected with 40 g of control vector and plated as described in A. Shh (squares), melatonin (triangles), or L-15 vehicle (circles) was then added to each well at time zero, and measurements were taken as described in A. Experiments were repeated four times, and the error bars show standard error of the mean. specific aspects of G␣ i signaling systems may offer chemical therapies for basal cell carcinomas. Inappropriate activation of G␣ i pathways is seen in tumors arising in tissues other than skin, including human adrenal cortex, ovary, and brain (27, 28) .
The experiments conducted in our study also demonstrate that the Ptc⅐Smo receptor complex, which initiates Shh signaling, can be reconstituted as a fully functional entity in the heterologous melanophore. As in its normal environment, the unliganded receptor complex shows no activity in melanophores as measured by the lack of Smo-mediated pigment aggregation, and this effect is sensitive to the amount of Ptc present in the cells. Further, the addition of Shh to the system overcomes the Ptc-controlled Smo blockade just as it can in tissues that normally contain Ptc and Smo. Finally, the ability of Shh protein to induce pigment aggregation in Ptc⅐Smo-expressing cells within 5 min rules out the need for new protein synthesis for Smo-mediated G␣ i activation. The results indicate that melanophores present a simple visual means for studying how Shh, Ptc, Smo, and G␣ i interact. We hope that in the future, the assay will help provide a more detailed understanding of the workings of the Shh signal transduction pathway at the level of the cell membrane.
